🔎 Trials Near Me

Akèy › Kansè Urojenital › Washington

Etid klinik pou Kansè Urojenital nan Washington, DC

6 etid pou Kansè Urojenital ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Oct 2, 2026 · NCT01174121

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Ap rekriteFaz 2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 72 · Tout sèks · Mizajou Sep 28, 2026 · NCT03412877

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04923178

Gender Related Coping and Survivorship for Genitourinary Cancers

Ap rekriteEtid obsèvasyon
  • Sibley Memorial Hospital, Washington D.C.
Laj 18 ak plis · Fanm · Mizajou Oct 3, 2025 · NCT05649306

Etid Kansè Urojenital nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.